KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $141.8 million.

  • Globus Medical's Net Cash Flow fell 3191.0% to $141.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$265.1 million, marking a year-over-year decrease of 17821.87%. This contributed to the annual value of $316.9 million for FY2024, which is 71.35% up from last year.
  • As of Q3 2025, Globus Medical's Net Cash Flow stood at $141.8 million, which was down 3191.0% from -$246.2 million recorded in Q2 2025.
  • Globus Medical's 5-year Net Cash Flow high stood at $208.3 million for Q3 2024, and its period low was -$326.7 million during Q1 2025.
  • In the last 5 years, Globus Medical's Net Cash Flow had a median value of $36.8 million in 2022 and averaged $6.0 million.
  • Over the last 5 years, Globus Medical's Net Cash Flow had its largest YoY gain of 758431.37% in 2021, and its largest YoY loss of 134123.63% in 2021.
  • Quarter analysis of 5 years shows Globus Medical's Net Cash Flow stood at -$168.6 million in 2021, then skyrocketed by 110.13% to $17.1 million in 2022, then skyrocketed by 1000.68% to $188.0 million in 2023, then fell by 11.74% to $166.0 million in 2024, then decreased by 14.55% to $141.8 million in 2025.
  • Its Net Cash Flow was $141.8 million in Q3 2025, compared to -$246.2 million in Q2 2025 and -$326.7 million in Q1 2025.